- Home
- PAHC vs CPF Comparison
PAHC vs CPF Comparison
Compare PAHC & CPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAHC
- CPF
- Stock Information
- Founded
- PAHC 1946
- CPF 1954
- Country
- PAHC United States
- CPF United States
- Employees
- PAHC N/A
- CPF N/A
- Industry
- PAHC Biotechnology: Pharmaceutical Preparations
- CPF Major Banks
- Sector
- PAHC Health Care
- CPF Finance
- Exchange
- PAHC Nasdaq
- CPF Nasdaq
- Market Cap
- PAHC 871.9M
- CPF N/A
- IPO Year
- PAHC 2014
- CPF N/A
- Fundamental
- Price
- PAHC $21.95
- CPF $27.31
- Analyst Decision
- PAHC Sell
- CPF Buy
- Analyst Count
- PAHC 4
- CPF 1
- Target Price
- PAHC $21.00
- CPF $30.00
- AVG Volume (30 Days)
- PAHC 242.0K
- CPF 156.6K
- Earning Date
- PAHC 05-07-2025
- CPF 04-23-2025
- Dividend Yield
- PAHC 2.19%
- CPF 3.96%
- EPS Growth
- PAHC 30.53
- CPF N/A
- EPS
- PAHC 0.48
- CPF 1.97
- Revenue
- PAHC $1,106,080,000.00
- CPF $240,575,000.00
- Revenue This Year
- PAHC $28.43
- CPF N/A
- Revenue Next Year
- PAHC $10.10
- CPF $6.49
- P/E Ratio
- PAHC $46.07
- CPF $13.86
- Revenue Growth
- PAHC 12.63
- CPF N/A
- 52 Week Low
- PAHC $12.30
- CPF $18.53
- 52 Week High
- PAHC $26.55
- CPF $33.25
- Technical
- Relative Strength Index (RSI)
- PAHC 45.76
- CPF 46.86
- Support Level
- PAHC $20.80
- CPF $26.32
- Resistance Level
- PAHC $22.41
- CPF $27.90
- Average True Range (ATR)
- PAHC 0.66
- CPF 0.59
- MACD
- PAHC 0.01
- CPF 0.08
- Stochastic Oscillator
- PAHC 50.56
- CPF 62.34
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.